A Study of LY2157299 Monohydrate in Healthy Volunteers



Status:Completed
Conditions:Healthy Studies
Therapuetic Areas:Other
Healthy:No
Age Range:Any
Updated:2/4/2013
Start Date:January 2013
End Date:February 2013
Contact:This is a single site clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Phone:1-317-615-4559

Use our guide to learn which trials are right for you!

Disposition of [14C]-LY2157299 Monohydrate Following Oral Administration in Healthy Subjects


This study involves a single dose of 150 milligram (mg) of radiolabeled LY2157299
monohydrate in healthy participants. The study will determine how the body eliminates the
radioactivity and LY2157299 monohydrate. Participants must be healthy surgically sterile or
postmenopausal females, or sterile males. This study is approximately 8 to 15 days.


Inclusion Criteria:

- Healthy surgically sterile females, postmenopausal females, or sterile males

- Body mass index (BMI) of 18.5 to 32.0 kilograms per square meter (kg/m^2)

- Have venous access sufficient to allow for blood sampling

Exclusion Criteria:

- Have known allergies to LY2157299, related compounds or any components of the
formulation

- Have an abnormal blood pressure as determined by the investigator

- Have participated in a [^14C]-study within the last 6 months prior to admission for
this study
We found this trial at
1
site
?
mi
from
Burlington, WI
Click here to add this to my saved trials